Blepharospasm Patient Survey for Patients With Blepharospasm

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

124 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-09-30

Study Completion Date

2013-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this survey is to collect detailed information on patients treated for blepharospasm with incobotulinumtoxinA, abobotulinumtoxinA and onabotulinumtoxinA, including how often they are treated with botulinum toxin, how long their treatment lasts, how satisfied they are with their treatment, and if there is any improvement in their symptoms with the treatment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of the Eyelid

NCT01896895

Bilateral Blepharospasm (BEB)

COMPLETED PHASE3

Comparison of Two Botulinum Type A Products in the Treatment of Blepharospasm

NCT00761592

Blepharospasm

COMPLETED PHASE4

Comparison of Korean Botulinum Toxin Type A Versus Botox in the Treatment of Essential Blepharospasm

NCT00682760

Blepharospasm

COMPLETED PHASE3

Pretarsal Versus Preseptal Botulinum Toxin for Patients With Eyelid Spasm

NCT03508882

Blepharospasm Hemifacial Spasm Botulinum Toxins, Type A

COMPLETED PHASE4

Comparison of Different Botulinum Toxin A Injection Patterns in the Treatment of Blepharospasm

NCT02327728

Blepharospasm

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is open to males and females \> 18 years and \< 81 years with a clinical diagnosis of blepharospasm.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Blepharospasm

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Blepharospasm Survey Group

No intervention- only one time survey

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention- only one time survey

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female subject aged \> 18 years and \< 81 years
* Documented clinical diagnosis of blepharospasm
* Currently receiving incobotulinumtoxinA, abobotulinumtoxinA or onabotulinumtoxinA